Cargando…
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor
Nerve growth factor is a therapeutic candidate for Alzheimer’s disease. Due to its pain-inducing activity, in current clinical trials nerve growth factor is delivered locally into the brain by neurosurgery, but data on the efficacy of local nerve growth factor delivery in decreasing amyloid-β deposi...
Autores principales: | Capsoni, Simona, Malerba, Francesca, Carucci, Nicola Maria, Rizzi, Caterina, Criscuolo, Chiara, Origlia, Nicola, Calvello, Mariantonietta, Viegi, Alessandro, Meli, Giovanni, Cattaneo, Antonino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379860/ https://www.ncbi.nlm.nih.gov/pubmed/28031222 http://dx.doi.org/10.1093/brain/aww271 |
Ejemplares similares
-
Intranasal “painless” Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice
por: Capsoni, Simona, et al.
Publicado: (2012) -
Correction: Intranasal “painless” Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice
por: Capsoni, Simona, et al.
Publicado: (2012) -
Getting Into the Brain: The Intranasal Approach to Enhance the Delivery of Nerve Growth Factor and Its Painless Derivative in Alzheimer’s Disease and Down Syndrome
por: Capsoni, Simona, et al.
Publicado: (2022) -
NGF steers microglia toward a neuroprotective phenotype
por: Rizzi, Caterina, et al.
Publicado: (2018) -
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a “Painless” Lead Investigational Candidate for Therapeutic Applications
por: Malerba, Francesca, et al.
Publicado: (2015)